Asian shares edged higher in choppy trading on Thursday, helped by advances in Chinese real estate shares, though fears about the Omicron variant of the new coronavirus capped gains regionally.
Asian factory activity grew in November as crippling supply bottlenecks eased, but rising input costs and renewed weakness in China dampened the region’s prospects for an early, sustained recovery from pandemic paralysis.
Airlines are bracing for a fresh round of volatility due to the Omicron variant of COVID-19 that could force them to adjust schedules and destinations at short notice and to rely more on domestic markets where possible, analysts say.
Australia and New Zealand Banking Group (ANZ.AX) has been sued by a law firm for charging interest on some purchases by credit card holders which were repaid on time for nearly a decade, the parties said on Wednesday.
A pileup of risks into year-end has some investors gauging whether December will continue its historical trend of a strong stock performance, even as markets face of worries over the Omicron coronavirus variant and a more hawkish Federal Reserve.
Germany’s incoming Finance Minister Christian Lindner on Tuesday vowed to champion solid public finances and a reduction of debt levels across the euro zone so that the European Central Bank (ECB) could fight inflation without hesitation if needed.
U.S. stock index futures fell sharply on Tuesday after a warning from vaccine maker Moderna’s chief executive on the effectiveness of COVID-19 shots against the Omicron variant hammered travel, energy and banking shares.
A major hit to the peak December travel season because of the Omicron variant of the coronavirus would cause “significant traumas” in the global aviation business, Emirates airline President Tim Clark said on Tuesday.
There was a fall in world share markets and scramble to safer currencies and bonds on Tuesday after the CEO of drugmaker Moderna (MRNA.O) warned that COVID-19 vaccines are unlikely to be as effective against the new Omicron variant.
The latest COVID-19 virus variant has sparked a wild ride in markets.
Asian shares edged higher in choppy trading on Thursday, helped by advances in Chinese real estate shares, though fears about the Omicron variant of the new coronavirus capped gains regionally.
Asian factory activity grew in November as crippling supply bottlenecks eased, but rising input costs and renewed weakness in China dampened the region’s prospects for an early, sustained recovery from pandemic paralysis.
Airlines are bracing for a fresh round of volatility due to the Omicron variant of COVID-19 that could force them to adjust schedules and destinations at short notice and to rely more on domestic markets where possible, analysts say.
Australia and New Zealand Banking Group (ANZ.AX) has been sued by a law firm for charging interest on some purchases by credit card holders which were repaid on time for nearly a decade, the parties said on Wednesday.
A pileup of risks into year-end has some investors gauging whether December will continue its historical trend of a strong stock performance, even as markets face of worries over the Omicron coronavirus variant and a more hawkish Federal Reserve.
Germany’s incoming Finance Minister Christian Lindner on Tuesday vowed to champion solid public finances and a reduction of debt levels across the euro zone so that the European Central Bank (ECB) could fight inflation without hesitation if needed.
U.S. stock index futures fell sharply on Tuesday after a warning from vaccine maker Moderna’s chief executive on the effectiveness of COVID-19 shots against the Omicron variant hammered travel, energy and banking shares.
A major hit to the peak December travel season because of the Omicron variant of the coronavirus would cause “significant traumas” in the global aviation business, Emirates airline President Tim Clark said on Tuesday.
There was a fall in world share markets and scramble to safer currencies and bonds on Tuesday after the CEO of drugmaker Moderna (MRNA.O) warned that COVID-19 vaccines are unlikely to be as effective against the new Omicron variant.
The latest COVID-19 virus variant has sparked a wild ride in markets.
© | All rights reserved.
